Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sialic acid binding Ig-like lectin 7 pseudogene (ENSG00000272714) is a pseudogene related to the active SIGLEC7 gene. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but do not encode a protein product and are generally not expressed. Thus, they do not serve as therapeutic targets, disease biomarkers, or have clinically relevant biological functions. If "Sialic acid binding Ig-like lectin 7" is intended, this gene encodes an inhibitory receptor of the I-type lectin family involved in regulation of natural killer (NK) cell activity and immune responses, but the pseudogene form is biologically inert[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sialic acid binding Ig-like lectin 7 pseudogene.